Systemic Redesign and Demonstration for Early Detection, Evaluation and Management of Chronic Kidney Disease in Shanghai (SCREENING)

March 21, 2017 updated by: Changlin Mei, Shanghai Changzheng Hospital
Based on clinical evidence based medicine and organizational management model, investigators redesign the prevention and treatment of chronic kidney disease of public health system in Shanghai China. The investigators hope to find early chronic kidney disease, prevention and clinical intervention of orderly combination. The advantages of this system were confirmed by comparing the prevalence rate, awareness rate and treatment rate before and after the completion of the system.

Study Overview

Status

Status

Indicates the current recruitment status or the expanded access status.
Unknown

Conditions

Conditions

The disease, disorder, syndrome, illness, or injury that is being studied. On ClinicalTrials.gov, conditions may also include other health-related issues, such as lifespan, quality of life, and health risks.

Detailed Description

The whole study mainly includes the following parts:

  1. Establishment of a database of patients with kidney disease, and training data entry specialist in every center.
  2. Conduct propaganda of kidney disease knowledge, training professional doctors in center hospital and community hospital.
  3. Search for high-risk patients, and screening for patients with kidney disease from community residents in community hospital.
  4. Establishment of a standardized and orderly patient referral process from community hospital to center hospital or three level of first-class hospital.

Study Type

Study Type

Describes the nature of a clinical study. Study types include interventional studies (also called clinical trials), observational studies (including patient registries), and expanded access.
Observational

Enrollment (Anticipated)

Enrollment

The number of participants in a clinical study. The "anticipated" enrollment is the target number of participants that the researchers need for the study.
2000000

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Contact

The name and contact information for the person who can answer enrollment questions for a clinical study. Each location where the study is being conducted may also have a specific contact, who may be better able to answer those questions.

Study Contact Backup

  • Name: Yiyi Ma, Doctor
  • Phone Number: +8613661679863
  • Email: dukemm@126.com

Study Locations

  • China
    • Shanghai
      • Shanghai, Shanghai, China, 200040
        • Recruiting
        • Huashan Hospital
      • Shanghai, Shanghai, China, 200003
        • Recruiting
        • Changzheng hospital
      • Shanghai, Shanghai, China, 200040
        • Recruiting
        • Jiangning Road Community Health Service Center of Shanghai
      • Shanghai, Shanghai, China, 200040
        • Recruiting
        • Jing'an District Central Hospital of Shanghai
      • Shanghai, Shanghai, China, 200040
        • Recruiting
        • Jing'an Temple Community Health Service Center of Shanghai
      • Shanghai, Shanghai, China, 200041
        • Recruiting
        • Second Shimen Road Community Health Service Center of Shanghai
      • Shanghai, Shanghai, China, 200041
        • Recruiting
        • West Nanjing road Community Health Services Center of Shanghai
      • Shanghai, Shanghai, China, 200042
        • Recruiting
        • Caojiadu Community Health Service Center of Shanghai
      • Shanghai, Shanghai, China, 200070
        • Recruiting
        • Jing'an District Zhabei Central Hospital of Shanghai
      • Shanghai, Shanghai, China, 200070
        • Recruiting
        • Tianmuxi Road Community Health Service Center of Shanghai
      • Shanghai, Shanghai, China, 200070
        • Recruiting
        • Zhijiangxi Road Community Health Service Center of Shanghai
      • Shanghai, Shanghai, China, 200071
        • Recruiting
        • Baoshan Community Health Services Center of Shanghai
      • Shanghai, Shanghai, China, 200071
        • Recruiting
        • Beizhan Community Health Service Center of Shanghai
      • Shanghai, Shanghai, China, 200072
        • Recruiting
        • Da'ning Community Health Services Center of Shanghai
      • Shanghai, Shanghai, China, 200072
        • Recruiting
        • Gonghexin Community Health Service Center of Shanghai
      • Shanghai, Shanghai, China, 200072
        • Recruiting
        • Pengpu zhen Community Health Services Center of Shanghai
      • Shanghai, Shanghai, China, 200240
        • Recruiting
        • Jiangchuan Community Health Service Center of Shanghai
      • Shanghai, Shanghai, China, 200240
        • Recruiting
        • The Fifth People's Hospital of Shanghai, Fudan University
      • Shanghai, Shanghai, China, 200241
        • Recruiting
        • Wujing Community Health Service Center of Shanghai
      • Shanghai, Shanghai, China, 200435
        • Recruiting
        • Linfen Community Health Services Center of Shanghai
      • Shanghai, Shanghai, China, 200435
        • Recruiting
        • Pengpu Community Health Services Center of Shanghai
      • Shanghai, Shanghai, China, 200443
        • Recruiting
        • Jing'an District Shibei Hospital of Shanghai
      • Shanghai, Shanghai, China, 201100
        • Recruiting
        • Minhang District Central Hospital of Shanghai
      • Shanghai, Shanghai, China, 201100
        • Recruiting
        • Xinhong Community Health Service Center of Shanghai
      • Shanghai, Shanghai, China, 201100
        • Recruiting
        • Xinzhuang Community Health Service Center of Shanghai
      • Shanghai, Shanghai, China, 201101
        • Recruiting
        • Qibao Community Health Service Center of Shanghai
      • Shanghai, Shanghai, China, 201102
        • Recruiting
        • Gumei Community Health Service Center of Shanghai
      • Shanghai, Shanghai, China, 201103
        • Recruiting
        • Hongqiao Community Health Service Center of Shanghai
      • Shanghai, Shanghai, China, 201104
        • Recruiting
        • Meilong Community Health Service Center of Shanghai
      • Shanghai, Shanghai, China, 201105
        • Recruiting
        • Longbai Community Health Service Center of Shanghai
      • Shanghai, Shanghai, China, 201107
        • Recruiting
        • Huacao Community Health Service Center of Shanghai
      • Shanghai, Shanghai, China, 201108
        • Recruiting
        • Zhuanqiao Community Health Service Center of Shanghai
      • Shanghai, Shanghai, China, 201111
        • Recruiting
        • Maqiao Community Health Service Center of Shanghai
      • Shanghai, Shanghai, China, 201112
        • Recruiting
        • Pujiang Community Health Service Center of Shanghai

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Eligibility Criteria

The key requirements that people who want to participate in a clinical study must meet or the characteristics they must have. Eligibility criteria consist of both inclusion criteria (which are required for a person to participate in the study) and exclusion criteria (which prevent a person from participating). Types of eligibility criteria include whether a study accepts healthy volunteers, has age or age group requirements, or is limited by sex.

Ages Eligible for Study

18 years and older (ADULT, OLDER_ADULT)

Accepts Healthy Volunteers

Yes

Genders Eligible for Study

All

Sampling Method

Non-Probability Sample

Study Population

The residents in Jing'an District and Minhang District, which medical services are provided by those collaborative Community Health Service Center.

Description

Inclusion Criteria:

  • Over 18 years of age.
  • Signed informed consent

Exclusion Criteria:

  • Refused to accept the blood and urine test

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort

Group / Cohort

A group or subgroup of participants in an observational study that is assessed for biomedical or health outcomes.
chronic kidney disease patients group
These patients were screened from 2000000 of the population. The investigator will compare the prevalence rate, awareness rate and treatment rate before and after the completion of the system. The degree of decreased glomerular filtration rate is also an important evaluation index.

What is the study measuring?

Primary Outcome Measures

Primary Outcome Measures

In a clinical study's protocol, the planned outcome measure that is the most important for evaluating the effect of an intervention/treatment. Most clinical studies have one primary outcome measure, but some have more than one.
Outcome Measure
Measure Description
Time Frame
prevalence rate of chronic kidney disease
Time Frame: baseline and 12 months, an average of 3 years
Change in prevalence rate of chronic kidney disease in shanghai from baseline to 3 years.
baseline and 12 months, an average of 3 years
awareness rate of chronic kidney disease
Time Frame: baseline and 12 months, an average of 3 years
Change in awareness rate of chronic kidney disease in shanghai from baseline to 3 years.
baseline and 12 months, an average of 3 years
treatment rate of chronic kidney disease
Time Frame: baseline and 12 months, an average of 3 years
Change in using standardized and orderly patient referral process from community hospital to center hospital or three level of first-class hospital. in shanghai from baseline to 3 years.
baseline and 12 months, an average of 3 years
The degree of decreased glomerular filtration rate in chronic kidney patients
Time Frame: through study completion, an average of 3 years
The degree of decreased glomerular filtration rate in chronic kidney patients, compared with healthy people and reported level in the literatures
through study completion, an average of 3 years

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Sponsor

The organization or person who initiates the study and who has authority and control over the study.
Shanghai Changzheng Hospital

Collaborators

Collaborators

An organization other than the sponsor that provides support for a clinical study. This support may include activities related to funding, design, implementation, data analysis, or reporting.
Huashan Hospital
Shanghai Municipal Commission of Health and Family Planning
Jing'an District Central Hospital of Shanghai
Shanghai Municipal Center for Disease Control and Prevention
The Fifth People's Hospital of Shanghai, Fudan University
Shanghai Minhang district Municipal Center for Disease Control and Prevention
Shanghai Jing'an district Municipal Center for Disease Control and Prevention
Minhang District Central Hospital of Shanghai
Jing'an District Zhabei Central Hospital of Shanghai
Jing'an District Shibei Hospital of Shanghai
Linfen Community Health Services Center of Shanghai
Pengpu Community Health Services Center of Shanghai
Pengpu zhen Community Health Services Center of Shanghai
Da'ning Community Health Services Center of Shanghai
Gonghexin Community Health Service Center of Shanghai
Zhijiangxi Road Community Health Service Center of Shanghai
Tianmuxi Road Community Health Service Center of Shanghai
Beizhan Community Health Service Center of Shanghai
Baoshan Community Health Services Center of Shanghai
West Nanjing road Community Health Services Center of Shanghai
Second Shimen Road Community Health Service Center of Shanghai
Jiangning Road Community Health Service Center of Shanghai
Caojiadu Community Health Service Center of Shanghai
Jing'an Temple Community Health Service Center of Shanghai
Xinzhuang Community Health Service Center of Shanghai
Longbai Community Health Service Center of Shanghai
Gumei Community Health Service Center of Shanghai
Xinhong Community Health Service Center of Shanghai
Huacao Community Health Service Center of Shanghai
Hongqiao Community Health Service Center of Shanghai
Qibao Community Health Service Center of Shanghai
Meilong Community Health Service Center of Shanghai
Jiangchuan Community Health Service Center of Shanghai
Zhuanqiao Community Health Service Center of Shanghai
Maqiao Community Health Service Center of Shanghai
Wujing Community Health Service Center of Shanghai
Pujiang Community Health Service Center of Shanghai

Investigators

Investigators

A researcher involved in a clinical study. Related terms include site principal investigator, site sub-investigator, study chair, study director, and study principal investigator.
  • Principal Investigator: Changlin Mei, Master, Shanghai Changzheng Hospital

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (ACTUAL)

Study Start

The actual date on which the first participant was enrolled in a clinical study. The "anticipated" study start date is the date that the researchers think will be the study start date.
October 1, 2015

Primary Completion (ANTICIPATED)

Primary Completion

The date on which the last participant in a clinical study was examined or received an intervention to collect final data for the primary outcome measure. Whether the clinical study ended according to the protocol or was terminated does not affect this date. For clinical studies with more than one primary outcome measure with different completion dates, this term refers to the date on which data collection is completed for all the primary outcome measures. The "anticipated" primary completion date is the date that the researchers think will be the primary completion date for the study.
December 31, 2017

Study Completion (ANTICIPATED)

Study Completion

The date on which the last participant in a clinical study was examined or received an intervention/treatment to collect final data for the primary outcome measures, secondary outcome measures, and adverse events (that is, the last participant's last visit). The "anticipated" study completion date is the date that the researchers think will be the study completion date.
June 1, 2018

Study Registration Dates

First Submitted

First Submitted

The date on which the study sponsor or investigator first submitted a study record to ClinicalTrials.gov. There is typically a delay of a few days between the first submitted date and the record's availability on ClinicalTrials.gov (the first posted date).
March 14, 2017

First Submitted That Met QC Criteria

First Submitted That Met QC Criteria

The date on which the study sponsor or investigator first submits a study record that is consistent with National Library of Medicine (NLM) quality control (QC) review criteria. The sponsor or investigator may need to revise and submit a study record one or more times before NLM's QC review criteria are met. It is the responsibility of the sponsor or investigator to ensure that the study record is consistent with the NLM QC review criteria.
March 14, 2017

First Posted (ACTUAL)

First Posted

The date on which the study record was first available on ClinicalTrials.gov after National Library of Medicine (NLM) quality control (QC) review has concluded. There is typically a delay of a few days between the date the study sponsor or investigator submitted the study record and the first posted date.
March 20, 2017

Study Record Updates

Last Update Posted (ACTUAL)

Last Update Posted

The most recent date on which changes to a study record were made available on ClinicalTrials.gov. There may be a delay between when the changes were submitted to ClinicalTrials.gov by the study's sponsor or investigator (the last update submitted date) and the last update posted date.
March 24, 2017

Last Update Submitted That Met QC Criteria

Last Update Submitted That Met QC Criteria

The most recent date on which the study sponsor or investigator submitted changes to a study record that are consistent with National Library of Medicine (NLM) quality control (QC) review criteria. It is the responsibility of the sponsor or investigator to ensure that the study record is consistent with the NLM QC review criteria.
March 21, 2017

Last Verified

Last Verified

The most recent date on which the study sponsor or investigator confirmed the information about a clinical study on ClinicalTrials.gov as accurate and current. If a study with a recruitment status of recruiting; not yet recruiting; or active, not recruiting has not been confirmed within the past 2 years, the study's recruitment status is shown as unknown.
March 1, 2017

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

Other Study ID Numbers

Identifiers or ID numbers other than the NCT number that are assigned to a clinical study by the study's sponsor, funders, or others. These numbers may include unique identifiers from other trial registries and National Institutes of Health grant numbers.
  • CZKIPLA-CKD-001

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Chronic Kidney Diseases

Search Similar Trials

Sponsors and Collaborators

Medical Conditions

Drug Interventions

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations

Cookie Settings

We use cookies to ensure that we give you the best experience on our website. For more details carefully read our Privacy and Cookies Policy. ...>>>You can change your preferences or withdraw your consent at any time by deleting the cookies from your website or computer as described in the policy. Please accept it and choose your preferences by ticking the corresponding boxes in the "Manage Settings" section below. Please carefully read our Terms of Service before you proceed with using any part of this website.
«Manage Settings